NCT01280357

Brief Summary

Clinical Investigation Protocol for a study designed to determine the equivalence of the Monica AN24 monitor to Philips 50XM for fetal heart rate (FHR) and uterine contraction (UC) monitoring during labor. The study will be carried out on subjects in the first and second stages of labor.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 19, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 20, 2011

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

March 21, 2013

Completed
Last Updated

March 21, 2013

Status Verified

March 1, 2013

Enrollment Period

4 months

First QC Date

January 19, 2011

Results QC Date

August 11, 2011

Last Update Submit

March 20, 2013

Conditions

Keywords

Fetal Heart Rate (FHR)Uterine Activity (UA)Labor & Delivery

Outcome Measures

Primary Outcomes (2)

  • The Mean Positive Percentage Agreement (PPA) for Fetal Heart Between Device 1 Monica AN24 & Device 2 Philips 50XM

    During Labor \& delivery, fetal heart rate was measured between the Monica AN24 \& the Philips 50XM and the waveforms of the 2 devices were measured to see the percentage of time they were in agreement.

    during labor and delivery the waveforms were measured for between 35 minutes and 15 hours during the first and second stage of labour

  • The Mean Positive Percentage Agreement (PPA) for Maternal Heart Between Device 1 Monica AN24 & Device 2 Philips 50XM

    During Labor \& delivery, maternal heart rate was measured between the Monica AN24 \& the Philips 50XM and the waveforms of the 2 devices were measured to see the percentage of time they were in agreement.

    during labor and delivery the waveforms were measured for between 35 minutes and 15 hours during the first and second stage of labour

Secondary Outcomes (1)

  • The Mean Positive Percentage Agreement for Uterine Contractions Between the Monica AN24 & The Philips 50XM

    between 35 mins & 15hrs during first & second stage labor

Study Arms (2)

Monitor Philips 50XM (K954351)

ACTIVE COMPARATOR

CTG Fetal Monitor If not confident of Monica AN24 displayed data then remove Monica AN24 monitor and continue monitoring with Philips 50XM

Device: Philips 50XM

Monica AN24 (K101801)

EXPERIMENTAL

EHG Fetal Monitor

Device: Monica AN24 (K101081)

Interventions

If not confident of Monica AN24 displayed data then remove Monica AN24 monitor and continue monitoring with Philips 50XM

Also known as: Philips Series 50XM (K954351)
Monica AN24 (K101801)

If not confident of Monica AN24 displayed data then remove Monica AN24 monitor and continue monitoring with Philips 50XM

Monitor Philips 50XM (K954351)

Eligibility Criteria

Age15 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pregnant, age 15-40
  • Term gestation (\>36 completed weeks)
  • Singleton fetus
  • Active labor
  • Vertex presentation
  • Requiring internal monitoring

You may not qualify if:

  • Clinical contraindication for Intra Uterine Pressure Catheter
  • Major fetal malformation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Queens Hospital Center

New York, New York, 11432, United States

Location

Temple University

Philadelphia, Pennsylvania, 19140, United States

Location

MeSH Terms

Conditions

Abortion, Habitual

Condition Hierarchy (Ancestors)

Abortion, SpontaneousPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Results Point of Contact

Title
Ian How
Organization
Monica Healthcare Ltd

Study Officials

  • Wayne Cohen, MD

    Queens Hospital Centre

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2011

First Posted

January 20, 2011

Study Start

February 1, 2010

Primary Completion

June 1, 2010

Study Completion

September 1, 2010

Last Updated

March 21, 2013

Results First Posted

March 21, 2013

Record last verified: 2013-03

Locations